HESTER BIOSCIENCES
|
The Current P/E Ratio of HESTER BIOSCIENCES is 16.28.
| Share Price | ₹2,482.1 | Jul 31,2026 |
| Market Cap | ₹2,109.7 Cr | |
| Earnings-TTM | ₹129.6 Cr | TTM-Consolidated Results |
| Price/Earnings | 16.28x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of HESTER BIOSCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,109.7 Cr] as on Jul 31,2026
(/) Earnings [ ₹129.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 16.28x ]
Thus, for HESTER BIOSCIENCES , the investors are currently willing to pay 16.28 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of HESTER BIOSCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of HESTER BIOSCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of HESTER BIOSCIENCES
PE Ratio Performance Analysis for HESTER BIOSCIENCES
- HESTER BIOSCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 45.60x.
- HESTER BIOSCIENCES 's operated at median p/e ratio of 48.58x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HESTER BIOSCIENCES 's p/e ratio peaked in Mar2024 at 62.57x.
- HESTER BIOSCIENCES 's p/e ratio hit its five-year low in Mar2026 of 19.31x.
How does HESTER BIOSCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| HESTER BIOSCIENCES | 129.56 | 16.28 | 2,109.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 39.21 | 477,312.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 83.29 | 213,879.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 90.03 | 194,094.0 |
| CIPLA LTD | 3,364.84 | 35.36 | 118,992.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.22 | 95,787.4 |
| MANKIND PHARMA LTD | 2,055.11 | 49.64 | 102,006.0 |
| LUPIN LTD | 5,355.47 | 20.61 | 110,374.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.36 | 112,369.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.95 | 90,872.3 |
| LAURUS LABS LTD | 1,090.76 | 89.96 | 98,126.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs HESTER BIOSCIENCES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.28x |
| Max industry PE | 90.03x |
| Median industry PE | 35.36x |
| Average industry PE | 45.72x |
You may also like the below Video Courses